person · Reporting owner
Whitley Richard James
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dogwood Therapeutics, Inc.DWTX · Entity 6845 | Director | June 16, 2026 | June 17, 2026 |
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | May 06, 2021 | May 07, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dogwood Therapeutics, Inc.
Report date June 16, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.50 · Expires 2036-06-16 | Direct | 16,800 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 16,800 · Balance 16,800 |
GILEAD SCIENCES, INC.
Report date May 06, 2021 · Filed May 07, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,058 |
Reported balance
After 2021-05-06 transaction · row 1
1 source rowRow 1 · 2021-05-06 · Exercise / conversion · Acquired 1,936 · Balance 33,058 F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 4,028 |
Reported balance
After 2021-05-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-05-06 · Exercise / conversion · Disposed 1,936 · Balance 4,028 F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: 100% of the restricted stock units vested on May 6, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2: 100% of the restricted stock units vested on May 6, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 17, 2026 17:17 UTC | Dogwood Therapeutics, Inc. DWTX · Entity 6845 | GrantStock Option (right to buy) · Derivative | 16,800 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001441661-26-000002 · form4-06172026_050636.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,800 Underlying: Common Stock · 16,800 shares Expires 2036-06-16 Read SEC document |
| June 27, 2025 Filed Jul 1, 2025 18:07 UTC | Dogwood Therapeutics, Inc. DWTX · Entity 6845 | GrantStock Option (right to buy) · Derivative | 2,362 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001415889-25-018651 · form4-07012025_060726.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,362 Underlying: Common Stock · 2,362 shares Expires 2035-06-27 Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 16:04 UTC | Dogwood Therapeutics, Inc. DWTX · Entity 6845 | GrantStock Option (right to buy) · Derivative | 210 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001415889-25-017940 · form4-06232025_040610.xml · derivative · entry 2 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420 Underlying: Common Stock · 210 shares Expires 2035-06-18 Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 16:04 UTC | Dogwood Therapeutics, Inc. DWTX · Entity 6845 | GrantStock Option (right to buy) · Derivative | 210 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001415889-25-017940 · form4-06232025_040610.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210 Underlying: Common Stock · 210 shares Expires 2035-06-18 Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 18:04 UTC | Dogwood Therapeutics, Inc. VIRI · Entity 6845 | GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001415889-24-005681 · form4-02282024_060200.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2034-02-26 F1 · derivative.exercise_date: The stock option will vest 100% on February 26, 2025, one year following the grant date. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 17:56 UTC | Dogwood Therapeutics, Inc. VIRI · Entity 6845 | GrantStock Option (right to buy) · Derivative | 5,250 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001415889-23-009985 · form4-06202023_050656.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,250 Underlying: Common Stock · 5,250 shares Expires 2033-06-15 F1 · derivative.exercise_date: The stock option will vest 100% on June 15, 2024, one year following the grant date. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 18:39 UTC | Dogwood Therapeutics, Inc. VIRI · Entity 6845 | SaleCommon Stock | 1,800 | $0.26 | $466.38 |
DisclosureSEC source: 0001415889-22-012370 · form4-12122022_061240.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Read SEC document |
| June 23, 2022 Filed Jun 30, 2022 18:09 UTC | Dogwood Therapeutics, Inc. VIRI · Entity 6845 | GrantStock Option (right to buy) · Derivative | 5,250 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001415889-22-007096 · form4-06302022_110649.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Common Stock · 5,250 shares Expires 2032-06-23 F1 · derivative.exercise_date: The stock option will vest 100% on June 23, 2023, one year following the grant date. Read SEC document |
| May 18, 2022 Filed May 19, 2022 15:48 UTC | Dogwood Therapeutics, Inc. VIRI · Entity 6845 | PurchaseCommon Stock | 500 | $4.53 | $2,262.50 |
DisclosureSEC source: 0001415889-22-005275 · form4-05192022_080533.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
| January 06, 2022 Filed Jan 7, 2022 18:14 UTC | Dogwood Therapeutics, Inc. VIRI · Entity 6845 | PurchaseCommon Stock | 1,800 | $5.72 | $10,296.00 |
DisclosureSEC source: 0001415889-22-000447 · form4-01072022_100133.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| December 23, 2021 Filed Dec 23, 2021 20:59 UTC | Dogwood Therapeutics, Inc. VIRI · Entity 6845 | PurchaseCommon Stock | 200 | $5.73 | $1,145.00 |
DisclosureSEC source: 0001415889-21-006204 · form4-12232021_121238.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 18:55 UTC | Dogwood Therapeutics, Inc. VIRI · Entity 6845 | GrantStock Option (right to buy) · Derivative | 7,875 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001415889-21-003154 · form4-06232021_110634.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,875 Underlying: Common Stock · 7,875 shares Expires 2031-06-22 F1 · derivative.exercise_date: The stock option will vest in 12 equal monthly installments following the grant date. Read SEC document |
| May 06, 2021 Filed May 7, 2021 22:53 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 1,936 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-015952 · form4.xml · derivative · entry 2 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,028 Underlying: Common Stock · 1,936 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 6, 2021. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 6, 2021. Read SEC document |
| May 06, 2021 Filed May 7, 2021 22:53 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 1,936 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-015952 · form4.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 03, 2021 Filed May 4, 2021 22:37 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 20,282 | $0.00 Strike: $20.65 | $0.00 |
DisclosureSEC source: 0001127602-21-015340 · form4.xml · derivative · entry 3 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,282 shares Expires 2021-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 12, 2012. Read SEC document |
| May 03, 2021 Filed May 4, 2021 22:37 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 20,282 | $64.57 | $1,309,655.39 |
DisclosureSEC source: 0001127602-21-015340 · form4.xml · nonDerivative · entry 2 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,122 F1 · price: Sale prices reported for the transactions reported here range from $64.56 to $64.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Read SEC document |
| May 03, 2021 Filed May 4, 2021 22:37 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 20,282 | $20.65 | $418,721.89 |
DisclosureSEC source: 0001127602-21-015340 · form4.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 23:47 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 62.9649 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012440 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,871.6977 Underlying: Common Stock · 62.9649 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 18:24 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 68.8983 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000084 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,808.7328 Underlying: Common Stock · 68.8983 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 23:09 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionPhantom Stock · Derivative | 1,434 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026596 · form4.xml · derivative · entry 2 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,739.8344 Underlying: Common Stock · 1,434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: An aggregate of 1434.958608 shares were reported in Table II when the reporting person acquired the phantom shares. The fractional share of 0.958608 was paid out in cash in connection with the conversion into shares of common stock. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 23:09 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 1,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026596 · form4.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 21:20 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 77.7136 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026051 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,174.793 Underlying: Common Stock · 77.7136 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| June 29, 2020 Filed Jul 1, 2020 21:03 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 64.1416 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-020666 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,097.0794 Underlying: Common Stock · 64.1416 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| May 06, 2020 Filed May 8, 2020 00:30 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 7,886 | $0.00 Strike: $77.47 | $0.00 |
DisclosureSEC source: 0001127602-20-015845 · form4.xml · derivative · entry 4 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,886 Underlying: Common Stock · 7,886 shares Expires 2030-05-06 F4 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 6, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 06, 2020 Filed May 8, 2020 00:30 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 1,936 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-015845 · form4.xml · derivative · entry 3 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,964 Underlying: Common Stock · 1,936 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 05, 2020 Filed May 8, 2020 00:30 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 2,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-015845 · form4.xml · derivative · entry 2 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,028 Underlying: Common Stock · 2,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 5, 2020. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 5, 2020. Read SEC document |
| May 05, 2020 Filed May 8, 2020 00:30 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 2,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-015845 · form4.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 18:20 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 62.4252 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-012372 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,032.9378 Underlying: Common Stock · 62.4252 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 21:30 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 66.9833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000167 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,970.5126 Underlying: Common Stock · 66.9833 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 68.4594 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-029286 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,903.5293 Underlying: Common Stock · 68.4594 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 23:40 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 63.5961 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-023299 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,835.07 Underlying: Common Stock · 63.5961 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| May 08, 2019 Filed May 10, 2019 21:24 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 11,848 | $0.00 Strike: $66.07 | $0.00 |
DisclosureSEC source: 0001127602-19-018180 · form4.xml · derivative · entry 2 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,848 Underlying: Common Stock · 11,848 shares Expires 2029-05-08 F3 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 8, 2019 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 8, 2020 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 08, 2019 Filed May 10, 2019 21:24 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 2,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-018180 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,298 Underlying: Common Stock · 2,270 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting. F2 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 07, 2019 Filed May 8, 2019 22:42 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 2,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-017787 · form4.xml · derivative · entry 2 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,028 Underlying: Common Stock · 2,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 7, 2019. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 7, 2019. Read SEC document |
| May 07, 2019 Filed May 8, 2019 22:42 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 2,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-017787 · form4.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 01, 2019 Filed May 2, 2019 22:48 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 9,534 | $0.00 Strike: $22.02 | $0.00 |
DisclosureSEC source: 0001127602-19-017100 · form4.xml · derivative · entry 3 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,534 shares Expires 2019-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 6, 2010. Read SEC document |
| May 01, 2019 Filed May 2, 2019 22:48 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 9,534 | $65.02 | $619,934.05 |
DisclosureSEC source: 0001127602-19-017100 · form4.xml · nonDerivative · entry 2 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,135 F2 · price: Sale prices reported for the transactions reported here range from $64.49 to $65.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Read SEC document |
| May 01, 2019 Filed May 2, 2019 22:48 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 9,534 | $22.02 | $209,891.01 |
DisclosureSEC source: 0001127602-19-017100 · form4.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 00:10 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 9,534 | $0.00 Strike: $22.02 | $0.00 |
DisclosureSEC source: 0001127602-19-014356 · form4.xml · derivative · entry 3 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,534 Underlying: Common Stock · 9,534 shares Expires 2019-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 6, 2010. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 00:10 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 9,534 | $65.48 | $624,254.86 |
DisclosureSEC source: 0001127602-19-014356 · form4.xml · nonDerivative · entry 2 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,135 F2 · price: Sale prices reported for the transactions reported here range from $65.25 to $65.67. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 00:10 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 9,534 | $22.02 | $209,891.01 |
DisclosureSEC source: 0001127602-19-014356 · form4.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 23:16 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 66.3251 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-013909 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,771.4738 Underlying: Common Stock · 66.3251 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| December 28, 2018 Filed Jan 2, 2019 22:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 61.1999 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-000353 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,705.1488 Underlying: Common Stock · 61.1999 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 22:55 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 49.0869 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-028859 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,643.9489 Underlying: Common Stock · 49.0869 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| June 28, 2018 Filed Jul 2, 2018 23:51 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 53.0193 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-022355 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,594.862 Underlying: Common Stock · 53.0193 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| May 09, 2018 Filed May 11, 2018 23:15 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 2,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-017245 · form4.xml · derivative · entry 2 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,311 Underlying: Common Stock · 2,283 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 09, 2018 Filed May 11, 2018 23:15 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 9,496 | $0.00 Strike: $65.69 | $0.00 |
DisclosureSEC source: 0001127602-18-017245 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,496 Underlying: Common Stock · 9,496 shares Expires 2028-05-09 F1 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary measured from May 9, 2018 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 9, 2019 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 23:32 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 49.0897 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013414 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,541.8427 Underlying: Common Stock · 49.0897 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| December 28, 2017 Filed Jan 2, 2018 23:32 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 46.2497 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000222 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,492.753 Underlying: Common Stock · 46.2497 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| September 28, 2017 Filed Oct 2, 2017 23:59 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 41.1664 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-028703 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,446.5033 Underlying: Common Stock · 41.1664 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.